pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
910
stories
Jun 2, 26
Celcuity breast cancer drug misses ‘lofty’ expectations in ASCO-spotlighted trial
biopharma dive
Jun 2, 26
STAT+: Longevity startup NewLimit raises $435 million ahead of first clinical trial
stat
Jun 2, 26
Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug
biopharma dive
Jun 2, 26
What’s next for VEGF? #ASCO26 offered clues, but answers will have to wait
endpoints
Jun 2, 26
STAT+: Radiopharmaceutical shows promise in post-Pluvicto setting
stat
Jun 2, 26
STAT+: Pharmalittle: We’re reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and more
stat
Jun 2, 26
AbiVax falls as safety worries cloud ‘landmark’ immune drug results
biopharma dive
Jun 2, 26
How one state’s medical meal program lowered health care costs
stat
Jun 2, 26
#ASCO26: Celcuity plans another FDA filing after positive breast cancer readout
endpoints
Jun 2, 26
#ASCO26: Roche details narrow failure of breast cancer pill trial
endpoints
Jun 2, 26
Fulcrum ends sickle cell ambitions following regulatory feedback, will seek exit
endpoints
Jun 2, 26
Cancer cases weigh down Abivax’s Phase 3 maintenance data in ulcerative colitis
endpoints
Jun 2, 26
ASCO ‘26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer
biopharma dive
Jun 2, 26
STAT+: Online care is caught in the crossfire as states crack down on corporate medicine
stat
Jun 1, 26
STAT+: Eli Lilly warns hospitals to submit claims data in the next five days or lose their 340B drug discounts
stat
Jun 1, 26
STAT+: Global coalition to fast-track three vaccines targeting Ebola outbreak with $62 million in funding
stat
Jun 1, 26
STAT+: Abivax ulcerative colitis drug shows strong efficacy, but cases of cancer raise concerns
stat
Jun 1, 26
STAT+: At ASCO, talk of barriers to cancer care, new treatments, and other big takeaways
stat
Jun 1, 26
STAT+: At the world’s largest cancer research meeting, data briefly took a backseat to grief
stat
Jun 1, 26
RallyBio tries again for reverse merger, this time with Avenzo
biopharma dive
Jun 1, 26
#ASCO26: Lilly's plenaries; Incyte's frontline data in lymphoma
endpoints
Jun 1, 26
Servier buys into muscular dystrophy with potentially $2.7B deal
biopharma dive
Jun 1, 26
As FDA misses deadline on electric shock ban, disability advocates speak out
stat
Jun 1, 26
STAT+: Medicare’s mum on GLP-1s, and Massachusetts sues United
stat
Jun 1, 26
STAT+: Pharmalittle: We’re reading about pancreatic and lung cancer drugs, China biotech growth, and more
stat
Jun 1, 26
Opinion: What should hospitals do when patients demand unvaccinated donor blood?
stat
Jun 1, 26
STAT+: A turning point for pancreatic cancer patients
stat
Jun 1, 26
STAT+: Servier to buy Edgewise Therapeutics’ muscular dystrophy drug
stat
Jun 1, 26
#ASCO26: AstraZeneca's triplet combo succeeds in liver cancer subgroup
endpoints
Jun 1, 26
#ASCO26: Erleada succeeds in early-stage prostate cancer study, but questions remain
endpoints
← prev
page 20 of 31
next →
